Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001853
Filing Date
2019-03-12
Accepted
2019-03-12 16:26:10
Documents
96
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ptgx-20181231x10k.htm 10-K 3409082
2 EX-21.1 ptgx-20181231ex211416cf2.htm EX-21.1 3772
3 EX-23.1 ptgx-20181231ex2313ee57b.htm EX-23.1 2924
4 EX-31.1 ptgx-20181231ex311cd46cf.htm EX-31.1 12650
5 EX-32.1 ptgx-20181231ex3213a81e3.htm EX-32.1 6969
6 GRAPHIC ptgx20181231x10k001.jpg GRAPHIC 57037
7 GRAPHIC ptgx20181231x10k002.jpg GRAPHIC 52683
8 GRAPHIC ptgx20181231x10k003.jpg GRAPHIC 20245
9 GRAPHIC ptgx20181231x10k004.jpg GRAPHIC 19421
10 GRAPHIC ptgx20181231x10k005.jpg GRAPHIC 28191
11 GRAPHIC ptgx20181231x10k006.jpg GRAPHIC 18011
12 GRAPHIC ptgx20181231x10k007.jpg GRAPHIC 19560
13 GRAPHIC ptgx20181231x10k008.jpg GRAPHIC 21578
14 GRAPHIC ptgx20181231x10k009.jpg GRAPHIC 45923
  Complete submission text file 0001558370-19-001853.txt   11923273

Data Files

Seq Description Document Type Size
15 EX-101.INS ptgx-20181231.xml EX-101.INS 2512663
16 EX-101.SCH ptgx-20181231.xsd EX-101.SCH 74027
17 EX-101.CAL ptgx-20181231_cal.xml EX-101.CAL 68579
18 EX-101.DEF ptgx-20181231_def.xml EX-101.DEF 296989
19 EX-101.LAB ptgx-20181231_lab.xml EX-101.LAB 572029
20 EX-101.PRE ptgx-20181231_pre.xml EX-101.PRE 525036
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37852 | Film No.: 19675401
SIC: 2834 Pharmaceutical Preparations